Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 5Heart Diseases 3Carcinoma, Non-Small-Cell Lung 3Vascular Diseases 2Cardiovascular Diseases 2Cardiotoxicity 2Small Cell Lung Carcinoma 1Metabolic Diseases 1Liver Neoplasms 1Hematologic Neoplasms 1Heart Failure 1Drug-Related Side Effects and Adverse Reactions 1Colorectal Neoplasms 1Colorectal Cancer Metastatic 1Cancer Therapy-related Cardiovascular Toxicity 1

Interventions

Hepatectomy 10Blood Specimen Collection 9Sorafenib 7Polymerase Chain Reaction 4Biopsy 4regorafenib 3Mass Spectrometry 3Liver Transplantation 3Immunohistochemistry 3Chemoembolization, Therapeutic 3Walking Speed 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Magnetic Resonance Imaging 2Gene Expression Profiling 2Bevacizumab 2trastuzumab deruxtecan 1taxane 1spartalizumab 1sintilimab 1lenvatinib 1gadolinium ethoxybenzyl DTPA 1donafenib 1carmofur 1camrelizumab 1cabozantinib 1atezolizumab 1apatinib 1anlotinib 1Yttrium-90 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Liver Neoplasms × Antineoplastic Agents × Clear all
NCT06777485 2025-08-20

China Liver Cancer Clinical Registry Cohort Database (HEAL)

Anhui Provincial Hospital

Recruiting
10,000 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡